Gastritis staging in clinical practice: the OLGA staging system.

PubWeight™: 1.90‹?› | Rank: Top 3%

🔗 View Article (PMC 1942143)

Published in Gut on December 01, 2006

Authors

Massimo Rugge1, Alberto Meggio, Gianmaria Pennelli, Francesco Piscioli, Luciano Giacomelli, Giovanni De Pretis, David Y Graham

Author Affiliations

1: Anatomia Patologica, Università degli Studi di Padova, Istituto Oncologico del Veneto IOV-IRCCS, Via Aristide Gabelli, 61, 35121 Padova, Italia. massimo.rugge@unipd.it

Articles citing this

Management of precancerous conditions and lesions in the stomach (MAPS): guideline from the European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter Study Group (EHSG), European Society of Pathology (ESP), and the Sociedade Portuguesa de Endoscopia Digestiva (SPED). Endoscopy (2011) 2.64

Effects of Helicobacter pylori treatment on gastric cancer incidence and mortality in subgroups. J Natl Cancer Inst (2014) 1.75

Kyoto global consensus report on Helicobacter pylori gastritis. Gut (2015) 1.47

Management of gastric polyps: an endoscopy-based approach. Clin Gastroenterol Hepatol (2013) 1.15

Role of deletion located between the intermediate and middle regions of the Helicobacter pylori vacA gene in cases of gastroduodenal diseases. J Clin Microbiol (2009) 1.13

Serological assessment of gastric mucosal atrophy in gastric cancer. BMC Gastroenterol (2012) 1.09

Risk for gastric neoplasias in patients with chronic atrophic gastritis: a critical reappraisal. World J Gastroenterol (2012) 1.06

Review of atrophic gastritis and intestinal metaplasia as a premalignant lesion of gastric cancer. J Cancer Prev (2015) 1.05

Prevention strategies for gastric cancer: a global perspective. Clin Endosc (2014) 1.04

Do we need multiple biopsies for assessing gastric cancer risk? Dig Dis Sci (2011) 1.04

The association of vacA genotypes and Helicobacter pylori-related gastroduodenal diseases in the Middle East. Eur J Clin Microbiol Infect Dis (2009) 1.04

Operative link for gastritis assessment vs operative link on intestinal metaplasia assessment. World J Gastroenterol (2011) 1.03

Management of precancerous conditions and lesions in the stomach (MAPS): guideline from the European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter Study Group (EHSG), European Society of Pathology (ESP), and the Sociedade Portuguesa de Endoscopia Digestiva (SPED). Virchows Arch (2011) 0.99

Seroprevalence of Helicobacter pylori infection and gastric mucosal atrophy in Bhutan, a country with a high prevalence of gastric cancer. J Med Microbiol (2013) 0.97

Additional corpus biopsy enhances the detection of Helicobacter pylori infection in a background of gastritis with atrophy. BMC Gastroenterol (2012) 0.96

Association between Helicobacter pylori and Barrett's esophagus: a case-control study. Am J Gastroenterol (2014) 0.96

Gastritis staging: interobserver agreement by applying OLGA and OLGIM systems. Virchows Arch (2014) 0.96

Gastric cancer, Helicobacter pylori infection and other risk factors. World J Gastrointest Oncol (2010) 0.96

The stomach in health and disease. Gut (2015) 0.95

Helicobacter pylori associated chronic gastritis, clinical syndromes, precancerous lesions, and pathogenesis of gastric cancer development. World J Gastroenterol (2014) 0.93

Utility of subtyping intestinal metaplasia as marker of gastric cancer risk. A review of the evidence. Int J Cancer (2013) 0.91

H. pylori infection is a key risk factor for proximal gastric cancer. Dig Dis Sci (2010) 0.89

Relationship between Helicobacter pylori hopQ genotype and clinical outcome in Asian and Western populations. J Gastroenterol Hepatol (2009) 0.89

Helicobacter pylori-Induced Chronic Gastritis and Assessing Risks for Gastric Cancer. Gastroenterol Res Pract (2013) 0.87

Chronic gastritis. Scand J Gastroenterol (2015) 0.87

Diagnosis and management of high risk group for gastric cancer. Gut Liver (2015) 0.86

DNA Methylation as Surrogate Marker For Gastric Cancer. J Cancer Prev (2015) 0.85

Gastric endoscopy in the 21st century: appropriate use of an invasive procedure in the era of non-invasive testing. Dig Liver Dis (2008) 0.84

Prospective, randomized, pathologist-blinded study of disposable alligator-jaw biopsy forceps for gastric mucosal biopsy. Dig Liver Dis (2008) 0.84

Serum pepsinogen and Helicobacter pylori infection--a Japanese population study. Eur J Clin Microbiol Infect Dis (2012) 0.83

Endoscopic gastritis, serum pepsinogen assay, and Helicobacter pylori infection. Korean J Intern Med (2016) 0.83

Molecular Epidemiology of Helicobacter pylori Infection in Nepal: Specific Ancestor Root. PLoS One (2015) 0.82

Interobserver and intraobserver agreement for gastric mucosa atrophy. BMC Gastroenterol (2015) 0.82

Prevalence of Helicobacter pylori infection and atrophic gastritis in patients with dyspeptic symptoms in Myanmar. World J Gastroenterol (2015) 0.82

Critical pathogenic steps to high risk Helicobacter pylori gastritis and gastric carcinogenesis. World J Gastroenterol (2014) 0.81

Virulence genes of Helicobacter pylori in the Dominican Republic. J Med Microbiol (2014) 0.81

Surveillance strategy of atrophic gastritis and intestinal metaplasia in a country with a high prevalence of gastric cancer. Dig Dis Sci (2011) 0.80

Helicobacter pylori Infection in Thailand: A Nationwide Study of the CagA Phenotype. PLoS One (2015) 0.80

Enhanced expression of activation-induced cytidine deaminase in human gastric mucosa infected by Helicobacter pylori and its decrease following eradication. J Gastroenterol (2013) 0.79

The Prevalence of Helicobacter pylori Virulence Factors in Bhutan, Vietnam, and Myanmar Is Related to Gastric Cancer Incidence. Biomed Res Int (2015) 0.79

Comparative analysis of upper gastrointestinal endoscopy, double-contrast upper gastrointestinal barium X-ray radiography, and the titer of serum anti-Helicobacter pylori IgG focusing on the diagnosis of atrophic gastritis. Gastric Cancer (2015) 0.78

Effect of miR-340 on gastric cancer cell proliferation and apoptosis. Int J Clin Exp Pathol (2015) 0.78

Secondary prevention of gastric cancer. Gut (2007) 0.78

Diagnostic Methods of Helicobacter pylori Infection for Epidemiological Studies: Critical Importance of Indirect Test Validation. Biomed Res Int (2016) 0.78

Serum Antibodies against Helicobacter pylori Neutrophil Activating Protein in Carriers of IL-4 C-590T Genetic Polymorphism Amplify the Risk of Gastritis and Gastric Cancer. Iran Biomed J (2016) 0.77

First-degree relatives of early-onset gastric cancer patients show a high risk for gastric cancer: phenotype and genotype profile. Virchows Arch (2013) 0.77

Helicobacter pylori associated gastric intestinal metaplasia: Treatment and surveillance. World J Gastroenterol (2016) 0.77

Atrophic and Metaplastic Progression in the Background Mucosa of Patients with Gastric Adenoma. PLoS One (2017) 0.77

Gastric Cancer: How Can We Reduce the Incidence of this Disease? Curr Gastroenterol Rep (2016) 0.76

Performance measures for upper gastrointestinal endoscopy: A European Society of Gastrointestinal Endoscopy quality improvement initiative. United European Gastroenterol J (2016) 0.76

Screening for and surveillance of gastric cancer. World J Gastroenterol (2014) 0.76

Mitochondrial DNA alterations in the progression of gastric carcinomas: unexplored issues and future research needs. World J Gastroenterol (2014) 0.75

Risk Profiles for Barrett's Esophagus Differ between New and Prevalent, and Long- and Short-Segment Cases. PLoS One (2016) 0.75

Gastric atrophy: use of OLGA staging system in practice. Gastroenterol Hepatol Bed Bench (2016) 0.75

Investigation of mucosal pattern of gastric antrum using magnifying narrow-band imaging in patients with chronic atrophic fundic gastritis. Ann Gastroenterol (2017) 0.75

Huangqi Jianzhong Tang for Treatment of Chronic Gastritis: A Systematic Review of Randomized Clinical Trials. Evid Based Complement Alternat Med (2015) 0.75

[Helicobacter pylori gastritis: assessment of OLGA and OLGIM staging systems]. Pan Afr Med J (2016) 0.75

Risk factors for under-diagnosis of gastric intraepithelial neoplasia and early gastric carcinoma in endoscopic forceps biopsy in comparison with endoscopic submucosal dissection in Chinese patients. Surg Endosc (2015) 0.75

Two populations of less-virulent Helicobacter pylori genotypes in Bangladesh. PLoS One (2017) 0.75

The serum pepsinogen levels for risk assessment of gastric neoplasms: New proposal from a case-control study in Korea. Medicine (Baltimore) (2017) 0.75

Articles cited by this

Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol (1996) 21.37

Histological grading and staging of chronic hepatitis. J Hepatol (1995) 19.57

Helicobacter pylori infection and the development of gastric cancer. N Engl J Med (2001) 17.13

Classification of chronic hepatitis: diagnosis, grading and staging. Hepatology (1994) 7.89

A human model of gastric carcinogenesis. Cancer Res (1988) 6.52

The Sydney System: histological division. J Gastroenterol Hepatol (1991) 5.49

Gastric dysplasia: the Padova international classification. Am J Surg Pathol (2000) 3.66

Interobserver variation in the histopathological assessment of Helicobacter pylori gastritis. Hum Pathol (1996) 3.57

Helicobacter pylori infection in the pathogenesis of duodenal ulcer and gastric cancer: a model. Gastroenterology (1997) 3.04

Intestinal metaplasia types and the risk of gastric cancer: a cohort study in Slovenia. Int J Cancer (1994) 2.74

Gastric mucosal atrophy: interobserver consistency using new criteria for classification and grading. Aliment Pharmacol Ther (2002) 1.94

Gastric cancer risk in chronic atrophic gastritis: statistical calculations of cross-sectional data. Int J Cancer (1985) 1.89

Liver biopsy sampling in chronic viral hepatitis. Semin Liver Dis (2004) 1.66

Chronic gastritis: a clinico-pathological classification. Am J Gastroenterol (1988) 1.56

The biological model of gastric carcinogenesis. IARC Sci Publ (2004) 1.53

Field cancerization, clonality, and epithelial stem cells: the spread of mutated clones in epithelial sheets. J Pathol (1999) 1.53

Intestinal metaplasia of the stomach. A status report. Cancer (1994) 1.37

The long term outcome of gastric non-invasive neoplasia. Gut (2003) 1.37

Staging and grading of chronic gastritis. Hum Pathol (2005) 1.31

Staging gastritis: an international proposal. Gastroenterology (2005) 1.29

Morphometric evaluation of gastric antral atrophy: improvement after cure of Helicobacter pylori infection. Am J Gastroenterol (2001) 1.26

Topographic patterns of intestinal metaplasia and gastric cancer. Am J Gastroenterol (2000) 1.24

Evaluation of gastric mucosal biopsy site and number for identification of Helicobacter pylori or intestinal metaplasia: role of the Sydney System. Hum Pathol (1999) 1.24

The epidemiology and pathogenesis of chronic gastritis: three etiologic entites. Front Gastrointest Res (1980) 1.16

Severe expression of corpus gastritis is characteristic in gastric cancer patients infected with Helicobacter pylori. Br J Cancer (1998) 1.15

Gastric epithelial dysplasia. How clinicopathologic background relates to management. Cancer (1995) 1.13

Chronic gastritis and gastroduodenal ulcer: a case control study on risk of coexisting duodenal or gastric ulcer in patients with gastritis. Gut (1989) 1.12

Assessment of gastric carcinoma risk associated with Helicobacter pylori may vary depending on the antigen used: CagA specific enzyme-linked immunoadsorbent assay (ELISA) versus commercially available H. pylori ELISAs. Cancer (2000) 1.11

Recognizing atrophy: another step toward a classification of gastritis. Am J Surg Pathol (1996) 1.10

Features of gastritis predisposing to gastric adenoma and early gastric cancer. J Clin Pathol (2002) 1.04

Histological classification of gastritis and Helicobacter pylori infection: an agreement at last? The International Workshop on the Histopathology of Gastritis. Helicobacter (1997) 1.04

Clinical impact of routine biopsies of the gastric antrum and body. Endoscopy (1997) 1.03

Gastritis and carditis. Mod Pathol (2003) 0.99

The classification of chronic gastritis: current status. J Clin Gastroenterol (1995) 0.92

Chronic nonatropic ('superficial') gastritis increases the risk of gastric carcinoma. A case-control study. Scand J Gastroenterol (1994) 0.89

Natural history of gastritis and its relationship to peptic ulcer disease. Digestion (1992) 0.89

Helicobacter pylori gastritis of the gastric carcinoma phenotype: is histology capable of identifying high-risk gastritis? J Gastroenterol (2000) 0.86

Patterns of inflammation linked to ulcer disease. Baillieres Best Pract Res Clin Gastroenterol (2000) 0.85

Regression of superficial gastric MALT lymphoma with unsuccessful eradication therapy for Helicobacter pylori infection. J Gastroenterol (1997) 0.79

Articles by these authors

(truncated to the top 100)

Management of Helicobacter pylori infection--the Maastricht IV/ Florence Consensus Report. Gut (2012) 12.62

Traces of human migrations in Helicobacter pylori populations. Science (2003) 11.92

Norwalk virus infection and disease is associated with ABO histo-blood group type. J Infect Dis (2002) 5.09

Norovirus vaccine against experimental human Norwalk Virus illness. N Engl J Med (2011) 3.78

Norwalk virus shedding after experimental human infection. Emerg Infect Dis (2008) 3.70

Obesity is an independent risk factor for GERD symptoms and erosive esophagitis. Am J Gastroenterol (2005) 3.34

Importance of Helicobacter pylori oipA in clinical presentation, gastric inflammation, and mucosal interleukin 8 production. Gastroenterology (2002) 3.27

The peopling of the Pacific from a bacterial perspective. Science (2009) 3.14

Proton pump inhibitor use and recurrent Clostridium difficile-associated disease: a case-control analysis matched by propensity score. J Clin Gastroenterol (2012) 2.99

Gastroesophageal reflux among different racial groups in the United States. Gastroenterology (2004) 2.87

Age at acquisition of Helicobacter pylori infection: a follow-up study from infancy to adulthood. Lancet (2002) 2.71

Helicobacter pylori in North and South America before Columbus. FEBS Lett (2002) 2.57

Determination of the 50% human infectious dose for Norwalk virus. J Infect Dis (2013) 2.50

A report card to grade Helicobacter pylori therapy. Helicobacter (2007) 2.41

Effect of interleukin 1 polymorphisms on gastric mucosal interleukin 1beta production in Helicobacter pylori infection. Gastroenterology (2002) 2.32

Serological correlate of protection against norovirus-induced gastroenteritis. J Infect Dis (2010) 2.21

Sequential and concomitant therapy with four drugs is equally effective for eradication of H pylori infection. Clin Gastroenterol Hepatol (2009) 2.15

Comparing the Blatchford and pre-endoscopic Rockall score in predicting the need for endoscopic therapy in patients with upper GI hemorrhage. Gastrointest Endosc (2010) 2.04

Duodenal ulcer promoting gene of Helicobacter pylori. Gastroenterology (2005) 2.03

An inter- and intra-laboratory comparison of breath ¹³CO₂analysis. Aliment Pharmacol Ther (2003) 2.03

Meta-analysis: four-drug, three-antibiotic, non-bismuth-containing "concomitant therapy" versus triple therapy for Helicobacter pylori eradication. Helicobacter (2009) 2.02

Optimal therapy for Helicobacter pylori infections. Nat Rev Gastroenterol Hepatol (2011) 1.98

A randomized prospective comparison of self-expandable plastic stents and partially covered self-expandable metal stents in the palliation of malignant esophageal dysphagia. Am J Gastroenterol (2007) 1.83

Risk factors for immediate and delayed bleeding associated with endoscopic submucosal dissection of gastric neoplastic lesions. Scand J Gastroenterol (2009) 1.75

NSAIDs, Helicobacter pylori, and Pandora's Box. N Engl J Med (2002) 1.75

Modified sequential Helicobacter pylori therapy: proton pump inhibitor and amoxicillin for 14 days with clarithromycin and metronidazole added as a quadruple (hybrid) therapy for the final 7 days. Helicobacter (2011) 1.73

Discrimination between cases of duodenal ulcer and gastritis on the basis of putative virulence factors of Helicobacter pylori. J Clin Microbiol (2002) 1.72

Patterns of gastric atrophy in intestinal type gastric carcinoma. Cancer (2002) 1.69

Biliary stenting in the management of large or multiple common bile duct stones. Gastrointest Endosc (2010) 1.68

Management of gastric polyps: a pathology-based guide for gastroenterologists. Nat Rev Gastroenterol Hepatol (2009) 1.62

Role of interferon-stimulated responsive element-like element in interleukin-8 promoter in Helicobacter pylori infection. Gastroenterology (2004) 1.59

Helicobacter pylori infection in mice: Role of outer membrane proteins in colonization and inflammation. Gastroenterology (2002) 1.58

Iron deficiency and Helicobacter pylori infection in the United States. Am J Epidemiol (2005) 1.57

Endoscopic demonstration of transient small bowel intussusception in a patient with adult celiac disease. Gastrointest Endosc (2003) 1.55

Barrett's epithelium after antireflux surgery. J Gastrointest Surg (2005) 1.52

Clinical usefulness of gastric-juice analysis in 2007: the stone that the builders rejected has become the cornerstone. Gastrointest Endosc (2007) 1.51

Helicobacter pylori-negative gastritis: prevalence and risk factors. Am J Gastroenterol (2012) 1.51

Barrett's esophagus and adenocarcinoma risk: the experience of the North-Eastern Italian Registry (EBRA). Ann Surg (2012) 1.50

Horizontal versus familial transmission of Helicobacter pylori. PLoS Pathog (2008) 1.48

Helicobacter pylori eradication and change in markers of iron stores among non-iron-deficient children in El Paso, Texas: an etiologic intervention study. J Pediatr Gastroenterol Nutr (2011) 1.47

Human nasal rhinosporidiosis: an Italian case report. Diagn Pathol (2006) 1.47

Liver steatosis in children with chronic hepatitis C. Am J Gastroenterol (2006) 1.46

Helicobacter pylori virulence factors: facts and fantasies. Curr Opin Gastroenterol (2005) 1.44

Etest for metronidazole susceptibility in H. pylori: use of the wrong standard may have led to the wrong conclusion. Am J Gastroenterol (2004) 1.43

Effect of the carbonic anhydrase inhibitor, acetazolamide, on Helicobacter pylori infection in vivo: a pilot study. Helicobacter (2005) 1.42

Waist-to-hip ratio, but not body mass index, is associated with an increased risk of Barrett's esophagus in white men. Clin Gastroenterol Hepatol (2012) 1.41

Expression of B7-H1 on gastric epithelial cells: its potential role in regulating T cells during Helicobacter pylori infection. J Immunol (2006) 1.41

Double-blind randomized trial of quadruple sequential Helicobacter pylori eradication therapy in asymptomatic infected children in El Paso, Texas. J Pediatr Gastroenterol Nutr (2011) 1.40

Helicobacter pylori infection--a boon or a bane: lessons from studies in a low-prevalence population. Helicobacter (2013) 1.38

Regulation of interleukin-6 promoter activation in gastric epithelial cells infected with Helicobacter pylori. Mol Biol Cell (2005) 1.37

Evaluation of the benefits and risks of low-dose aspirin in the secondary prevention of cardiovascular and cerebrovascular events. Arch Intern Med (2002) 1.35

Molecular epidemiology and outcome of Helicobacter pylori infection in Thailand: a cultural cross roads. Helicobacter (2004) 1.35

Clinical presentation in relation to diversity within the Helicobacter pylori cag pathogenicity island. Am J Gastroenterol (2002) 1.34

Diagnosis and management of iron deficiency anemia in the 21st century. Therap Adv Gastroenterol (2011) 1.30

Helicobacter pylori infection in Kazakhstan: effect of water source and household hygiene. Am J Trop Med Hyg (2002) 1.29

PDCD4 nuclear loss inversely correlates with miR-21 levels in colon carcinogenesis. Virchows Arch (2011) 1.28

Eradication of gastric cancer is now both possible and practical. Semin Cancer Biol (2013) 1.28

Correlation between Helicobacter pylori OipA protein expression and oipA gene switch status. J Clin Microbiol (2004) 1.27

Pharmacologic aspects of eradication therapy for Helicobacter pylori Infection. Gastroenterol Clin North Am (2010) 1.26

Helicobacter pylori and hetertopic gastric mucosa in the upper esophagus (the inlet patch). Am J Gastroenterol (2003) 1.25

Rationale, design, and governance of Prospective Randomized Evaluation of Celecoxib Integrated Safety versus Ibuprofen Or Naproxen (PRECISION), a cardiovascular end point trial of nonsteroidal antiinflammatory agents in patients with arthritis. Am Heart J (2009) 1.24

Liver tumorigenicity promoted by microRNA-221 in a mouse transgenic model. Hepatology (2012) 1.23

Importance of atrophic gastritis in diagnostics and prevention of gastric cancer: application of plasma biomarkers. Scand J Gastroenterol (2007) 1.22

Helicobacter pylori virulence and cancer pathogenesis. Future Oncol (2014) 1.21

Natural history, diagnosis, treatment and outcome of papillary thyroid microcarcinoma (PTMC): a mono-institutional 12-year experience. Nucl Med Commun (2004) 1.21

Is there a benefit to extending the duration of Helicobacter pylori sequential therapy to 14 days? Helicobacter (2011) 1.21

Serological responses to experimental Norwalk virus infection measured using a quantitative duplex time-resolved fluorescence immunoassay. Clin Vaccine Immunol (2011) 1.20

Increasing the duration of dual amoxicillin plus omeprazole Helicobacter pylori eradication to 6 weeks: a pilot study. J Gastroenterol Hepatol (2012) 1.20

Molecular characteristics in papillary thyroid cancers (PTCs) with no 131I uptake. Clin Endocrinol (Oxf) (2007) 1.20

Helicobacter pylori activate epidermal growth factor receptor- and phosphatidylinositol 3-OH kinase-dependent Akt and glycogen synthase kinase 3beta phosphorylation. Cell Microbiol (2008) 1.19

Helicobacter pylori impairs DNA mismatch repair in gastric epithelial cells. Gastroenterology (2002) 1.19

FDG-PET/CT and parathyroid carcinoma: Review of literature and illustrative case series. World J Clin Oncol (2011) 1.19

vacA i-region subtyping. Gastroenterology (2008) 1.18

Diet, lifestyle and gender in gastro-esophageal reflux disease. Dig Dis Sci (2007) 1.16

BRAF analysis by fine needle aspiration biopsy of thyroid nodules improves preoperative identification of papillary thyroid carcinoma and represents a prognostic factor. A mono-institutional experience. Clin Chem Lab Med (2010) 1.15

Management of gastric polyps: an endoscopy-based approach. Clin Gastroenterol Hepatol (2013) 1.15

Visceral abdominal obesity measured by CT scan is associated with an increased risk of Barrett's oesophagus: a case-control study. Gut (2013) 1.14

Role of deletion located between the intermediate and middle regions of the Helicobacter pylori vacA gene in cases of gastroduodenal diseases. J Clin Microbiol (2009) 1.13

Comparison of genotyping Helicobacter pylori directly from biopsy specimens and genotyping from bacterial cultures. J Clin Microbiol (2003) 1.13

Regulation of RANTES promoter activation in gastric epithelial cells infected with Helicobacter pylori. Infect Immun (2005) 1.12

Cross-reactivity of anti-CagA antibodies with vascular wall antigens: possible pathogenic link between Helicobacter pylori infection and atherosclerosis. Circulation (2002) 1.11

The Role of CD44 in the Pathogenesis, Diagnosis, and Therapy of Gastric Cancer. Gut Liver (2011) 1.11

Molecular markers in Helicobacter pylori-associated gastric carcinogenesis. Clin Lab Med (2005) 1.11

Serum hemagglutination inhibition activity correlates with protection from gastroenteritis in persons infected with Norwalk virus. Clin Vaccine Immunol (2011) 1.10

Which Therapy for Helicobacter pylori Infection? Gastroenterology (2012) 1.10

Genetic analysis of Helicobacter pylori strain populations colonizing the stomach at different times postinfection. J Bacteriol (2007) 1.09

Helicobacter pylori research: historical insights and future directions. Nat Rev Gastroenterol Hepatol (2013) 1.09

Gastric mucosal interleukin-17 and -18 mRNA expression in Helicobacter pylori-induced Mongolian gerbils. Cancer Sci (2009) 1.09

Polyflex stents for malignant oesophageal and oesophagogastric stricture: a prospective, multicentric study. Eur J Gastroenterol Hepatol (2007) 1.08

Strategy for eliminating gastric cancer in Japan. Helicobacter (2010) 1.08

Helicobacter pylori BabA expression, gastric mucosal injury, and clinical outcome. Clin Gastroenterol Hepatol (2006) 1.08

Randomized, double-blind, pilot study of geranylgeranylacetone versus placebo in patients taking low-dose enteric-coated aspirin. Low-dose aspirin-induced small bowel damage. Scand J Gastroenterol (2010) 1.07

The intact dupA cluster is a more reliable Helicobacter pylori virulence marker than dupA alone. Infect Immun (2011) 1.06

Sociocultural and dietary practices among Malay subjects in the north-eastern region of Peninsular Malaysia: a region of low prevalence of Helicobacter pylori infection. Helicobacter (2012) 1.06

Functional and intracellular signaling differences associated with the Helicobacter pylori AlpAB adhesin from Western and East Asian strains. J Biol Chem (2007) 1.06

Errors and near misses in digestive endoscopy units. Dig Liver Dis (2012) 1.05

OipA plays a role in Helicobacter pylori-induced focal adhesion kinase activation and cytoskeletal re-organization. Cell Microbiol (2007) 1.03

Polyomavirus shedding in the stool of healthy adults. J Clin Microbiol (2009) 1.03

Operative link for gastritis assessment vs operative link on intestinal metaplasia assessment. World J Gastroenterol (2011) 1.03

Prevention of gastric cancer by Helicobacter pylori eradication. Intern Med (2010) 1.03